New PCS codes were released late last week and are effective Aug. 1, 2020. The codes are considered V37.2. There are 12 new procedure codes, and they are related to COVID-19.
The good news is that these procedure codes are not designated as DRG OR procedures, so they do not affect the MS-DRG assignment. They can all be found in the New Technology section and Anatomic Region body system of ICD-10-PCS. Six new procedures incorporate three new substances related to treating COVID-19: Remdesivir Anti-Infective, Sarilumab, and Tocilizumab.
There have been studies regarding Remdesivir’s effectiveness in treating COVID-19. The early results show that this drug has shortened patients’ recovery time. Sarilumab is also known as Kevzara, and is used to treat rheumatoid arthritis. The clinical trials related to this drug have been stopped due to disappointing results. Tocilizumab is another drug that is used to treat rheumatoid arthritis, as well as cytokine release syndrome. The initial results of the clinical trials are promising in reducing the risk of invasive mechanical ventilation for patients who have pneumonia with COVID-19.
The approach for these substances is percutaneous, and includes body parts of central and peripheral vein. The root operation is Introduction and the Qualifier is New Technology Group 5, which indicates the 2020 fiscal year.
Two new codes are for the transfusion of convalescent plasma, non-autologous. This substance is found in patients who have recovered from COVID-19 and have antibodies for the disease. The plasma is separated from the blood of a recovered patient who has not had any COVID-19 symptoms for at least 14 days. The convalescent plasma is then transfused into a COVID-19 patient. This treatment is still in clinical trials, without any posted results.
These new codes use the root operation of Transfusion in the New Technology Section. The Approach is percutaneous, with Body Parts of central and peripheral vein. The Qualifier is New Technology Group 5.
Another new development in this release of new PCS codes is the creation of codes for the substance of “Other New Technology Therapeutic Substance.” It is thought that this alternative could be used for new substances that do not have an appropriate other alternative. The approaches include percutaneous and external. The body parts are central vein, peripheral vein, mouth, and pharynx, along with subcutaneous tissue. The Qualifier is New Technology Group 5.
These new codes were effective Aug. 1, 2020, but encoder companies are busy trying to update their encoder software. While you are waiting for the update, please prepare for these new codes. Here are some action items:
This late release of new procedure codes is unprecedented, but we are not usually immersed in a pandemic. Take some time to determine how you want the information to be used. Involve other people at your facility before you make decisions on how to utilize these new codes. Remember that the codes do not affect MS-DRG assignment, so there is no rush.
Think of the release of these new codes as Christmas in July: the gift of new PCS codes.
-19
.
Programming Note:
Laurie Johnson is a permanent panelist on Talk Ten Tuesdays. Listen to her coding report during Talk Ten Tuesdays, 10-10:30 a.m. EST.
In 2019, I had an employee health exam, and fortuitously but startlingly discovered I had no sight in my left eye. I rushed my butt
Did you know it is Sepsis Awareness Month? To be honest, I didn’t, until a recent Agency for Healthcare Research and Quality (AHRQ) newsletter informed
Please log in to your account to comment on this article.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
